Addressing myocardial infarction in South-Asian populations: risk factors and machine learning approaches

Addressing myocardial infarction in South-Asian populations: risk factors and machine learning approaches

Introduction

Myocardial infarction (MI) is a leading cause of death globally, contributing to nearly 17.9 million annual deaths, significantly impacting healthcare systems and economic productivity1. Certain ethnic populations2,3, particularly South Asians, experience higher rates of MI, with onset about a decade earlier, and face more severe post-MI complications compared to Western populations4,5,6,7. This increased risk is largely attributed to genetic predispositions, lifestyle, environmental factors, and higher rates of diabetes, dyslipidemia, and central obesity6,7,8. The INTERHEART study, which analyzed risk factors for acute MI in 52 countries, identified smoking, psychosocial stress, physical inactivity, and poor diet as key risk factors for acute MI in South Asians6. Despite their disproportionately higher rates of MI and post-MI complications, research focusing on the South Asian populations is relatively scarce.

Traditional risk scores, such as the ASCVD risk estimator, Framingham Risk Score, and QRISK, often underestimate cardiovascular risk in South Asians9,10, while the INTERHEART6 Modifiable Risk Score is based on case-control data11. Additionally, a cohort study from Norway found that the NORRISK 2 model underestimated the CVD risk in South Asian immigrants by a twofold difference12. Furthermore, WHO cardiovascular risk charts have been shown to misclassify high-risk South Asians as low-risk with higher prevalence13. These findings highlight the need for more accurate tools tailored to the unique risk profile of South Asian patients.

Given the limitations of existing risk assessment tools for South Asians, clinicians often rely on other methods and parameters. The Mediators of Atherosclerosis in South Asians Living in America (MASALA) study found the coronary artery calcium score to be a very specific marker for subclinical atherosclerosis14. Additionally, the INTERHEART study found the ApoB/ApoA-1 ratio to be a reliable biomarker for predicting CVD risk15. Thus, it is crucial to identify South Asians at risk of MI and enhance the detection of MI among symptomatic patients using advanced methods. Machine learning (ML) has shown potential in improving diagnostic and predictive capabilities. However, a significant research gap continues to exist in ML applications for CV diagnostics tailored to South Asians. This review aims to explore the risk factors for MI in the South Asian population and understand the applications of artificial intelligence (AI) and its subsets of ML and deep learning (DL) in such high-risk populations.

Cardiovascular diseases and MI among South Asians

Cardiovascular disease (CVD) is an important cause of death among South Asians, particularly in India16, where 52% of deaths before age 70 are attributable to CVD, compared to 23% in Western populations17,18. South Asians face a 40% higher risk of mortality from MI compared to other populations4,19,20. The economic impact is substantial, with India projected to lose $237 billion in productivity due to CVD4,17.

The higher CVD burden among South Asians suggests that ethnicity by itself may be a significant risk factor21,22. South Asians tend to develop metabolic abnormalities at a lower BMI and waist circumference than their White counterparts23, suggesting genetic and ecological influences on cardiovascular outcomes. Cohort studies in rural South India identify tobacco use, alcohol consumption, hypertension, diabetes mellitus, and obesity as significant risk factors9,20. Low physical activity, reduced muscle mass, and central accumulation of ectopic fat also correlate with elevated risk in South Asians. While primary prevention measures, such as exercise and dietary changes, have been effective in the United States, they are underutilized in India, where evidence-based treatments are alarmingly low17,24.

Traditional cardiovascular risk factors, such as blood pressure, cholesterol, smoking, and diabetes mellitus, are commonly used to calculate risk scores for premature MI across all ethnicities. The Framingham risk score25, introduced in 1998, estimates the 10-year cardiovascular risk of individuals based on data from the Framingham heart study, a multigenerational study identifying common factors for CVD. However, this score has limitations; it underestimates CVD risk among certain populations, including South Asians26. However, risk factors more prevalent among South Asians, such as insulin resistance and differential body fat distribution, are often underrecognized27. The MASALA study highlighted that the typical South Asian vegetarian diet correlates with higher insulin resistance and lower HDL cholesterol levels, leading to a greater risk of MI14. The study also showed that the prevalence of CVD risk factors may differ by South Asian subgroup: hypertension was most prevalent in North Indians compared to South Indians and Pakistanis, while dyslipidemia was highest in South Indians and Pakistanis28. Other studies have shown similar instances of cardiovascular risk heterogeneity within the South Asian population: Population-based analysis of five major Asian groups showed that Bangladeshis have a greater prevalence of diabetes as compared to Pakistanis and Indians, while a cohort study indicated an elevated proportional hazard of ASCVD incidence compared to Pakistani and Indian subgroups4,29.

Developing a CVD risk calculator tailored to South Asians is crucial for addressing these unique risk factors (Fig. 1) and enhancing prevention strategies. However, research is limited by inadequate data, unreliable clinical event reporting, and insufficient information on risk factor exposure patterns, including diet, physical activity, abdominal obesity, alcohol intake, and psychosocial factors30. Thus, a comprehensive framework outlining the multifactorial—genetic, economic, sociological, and dietary—causes of premature CVD and MI in South Asians is needed.

Fig. 1: Important Traditional and South Asian specific risk factors for myocardial infarction.
Addressing myocardial infarction in South-Asian populations: risk factors and machine learning approaches

The left panel displays traditional risk factors for ASCVD, while the right panel highlights the risk factors that are more specific and prevalent in the South Asian population.

Full size image

Risk factors for CVD among South Asians

Genetic factors

The heritability of CVD risk factors is well documented among close relatives, but recent studies have focused on the genetic contribution to population-level CVD risk31,32,33,34,35,36,37,38. In South Asian populations, genetic variations manifest in various potential phenotypic traits such as increased visceral obesity, high waist-to-hip ratios, dyslipidemia (high triglyceride and low HDL levels), hyperglycemia, elevated blood pressure, and smaller diameter of coronary vessels39,40,41,42,43,44,45.

Genome-wide association studies (GWAS) facilitated by next-generation sequencing have identified genetic loci and polymorphisms linked to common CVD risk factors33,34,37,38,46. Although the exact mechanisms driving CVD risk in South Asians are not fully understood, population-specific genetic polymorphisms are believed to play a significant role35,36,37. South Asians demonstrate a higher prevalence of prediabetes and diabetes mellitus, which are significant cardiovascular risk factors. The combination of these genetic traits substantially increases the incidence of CVD in this population16. Comprehensive genetic research is crucial to developing targeted prevention and treatment strategies for CVD in South Asians.

Research indicates that common disease variants account for only a modest portion of total disease heritability. There is substantial interest in the impact of rare disease variants, which are more likely to differ between ethnic groups47,48,49,50,51,52,53,54. Further genetic analysis of the South Asian population is essential to elucidate the extent to which these polymorphisms contribute to CVD risk55. Additionally, the South Asian population is genetically diverse and not homogenous, necessitating detailed subgroup analyses19.

Socioeconomic factors

Over the past fifty years, South Asia has transitioned from an agrarian-based economy to one dominated by manufacturing and service sectors, leading to significant reductions in physical activity and changes in dietary habits56,57. This economic shift has been linked to an increase in MI among the South Asian population57,58. Despite economic advancements, South Asia remains a significant center of global poverty, with 389 million people classified as multidimensionally poor (MPI poor) as of 2023, accounting for over 35% of the global MPI poor population56,59. Low socioeconomic status (SES) in the region is strongly associated with increased CVD risk factors60, including poor diet quality, substance abuse, reduced health screening, and mental health disorders61,62,63,64,65,66. Low SES during childhood is also linked to higher blood pressure in adulthood62. The prohibitive cost of CVD care exacerbates poverty, leading to catastrophic healthcare spending and lower employment rates in affected households. This is worsened by the fact that members of CVD-affected households also experience lower rates of employment as well67,68,69,70.

Consequently, more studies exploring the impact of SES on CVD risk in South Asian populations are necessary to understand deviation from global trends and how economics impact population-level CVD risk in South Asians. Interestingly, some studies in South Asia have revealed that high SES, rather than low SES, is associated with a higher risk of CVD and related risk factors, including obesity, physical inactivity, diabetes mellitus, hypertension, and dyslipidemia61,63.

Incorporating economic factors into cardiovascular risk scores is crucial for providing a comprehensive understanding of an individual’s risk profile, capturing the interplay between financial stability and health outcomes. This will enable more effective prevention and management strategies tailored to the unique needs of the South Asian population.

Dietary factors

The intricate relationship between diet and MI among South Asians necessitates an in-depth examination, considering the regional diversity of dietary patterns. South Asian diets traditionally include a variety of vegetables, pulses, cereals, and potatoes rich in whole grains, fiber, and complex carbohydrates, with notable regional distinctions. However, urbanization and advancements in food processing have led to adverse lifestyle and diet changes, such as increased processed food intake and deep-frying cooking71. This refined carbohydrates-based diet, rich in sugar and saturated and trans fatty acids, and low in proteins, monounsaturated fatty acids (MUFAs), and ω-3 polyunsaturated fatty acids (PUFAs), is suggested to contribute to elevated CAD risk, obesity, and insulin resistance in South Asians71,72. As grains are a staple to the South Asian diet, comprising 60-70% of total energy intake, micronutrient-poor refined grain intake contributes to the increased cardiometabolic risk associated with elevated triglycerides, lower HDL cholesterol, and prevalence of metabolic syndrome in South Asians73. While Kanaya et al.74 and Molina et al. 75 did not demonstrate a direct association of HDL-to-triglyceride ratio with coronary artery calcification, the low HDL-to-triglyceride ratio was noted to be an important surrogate marker of insulin resistance in the South Asian population by Flowers et al.76.

Regional dietary habits play a central role in understanding MI and cardiovascular risk among South Asian populations. The Pakistan Risk of Myocardial Infarction Study (PROMIS) highlighted genetic determinants, lifestyle, and dietary factors as critical determinants of CAD in South Asians, linking high-fat diets with increased MI risk77. In Bangladesh, younger adults with acute MI showed significant associations with unhealthy dietary habits, including high rice and beef consumption and lower intakes of fruits and vegetables78. A study in Sri Lanka also indicated that high dietary intake of meat, along with alcohol consumption and smoking, were significant risk factors for MI among young males79. Further, in a cross-sectional analysis conducted by Daniel et al. of dietary habits across Delhi, Mumbai, and Trivandrum, regional variations in diet composition was found to have significant associations with chronic disease outcomes80.

Specifically, South Indian diets rich in pulses and vegetables were inversely associated with hypertension and diabetes mellitus prevalence. In contrast, diets rich in high glycemic index foods such as high-fat dairy, and fried foods, were linked to increased abdominal adiposity and a high cardiometabolic risk profile. Other studies have affirmed that high-fat intake—including high sugar intake and use of ghee rich in saturated fat—and low consumption of fruits and vegetables are risk factors for premature cardiovascular events such as MI in young South Asians5,81. Thus, dietary patterns among South Asian populations are complex and vary significantly by region. Low-fat, pulse-based diets in southern regions provide protective benefits against diabetes mellitus and hypertension, while high-fat diets in northern regions contribute to a higher cardiovascular risk profile. These findings emphasize the need to integrate dietary habits into the risk score to address the unique risk factors specific to different South Asian communities.

In summary, we propose developing a novel risk score specifically designed to predict the risk of MI among South Asians82. By incorporating major risk factors identified in prior research, including genetic, economic, sociological, and dietary factors, a risk score metric that accurately quantifies the odds of a South Asian individual experiencing an MI, can be obtained. Integrating AI will be beneficial for understanding and capturing the increased risk, as it can enhance predictive accuracy and identify complex patterns in the data. This approach requires thorough validation and depends on data quality.

What is AI?

AI is an interdisciplinary field encompassing computer science, statistics, psychology, neuroscience, philosophy, control theory, and mathematics. It aims to perform tasks that typically require human intellect, such as problem-solving, building intelligent agents, navigating complex environments, knowledge representation, inference, planning, visual perception, decision-making, and language translation83.

ML, a subset of AI, involves developing algorithms and models to identify implicit patterns or relationships in data with minimal human intervention. ML consists of a model, a learning algorithm, and a task84. In contrast to traditional programming, ML algorithms learn from datasets and are able to explore both linear and non-linear relationships between variables. ML is categorized into supervised and unsupervised learning. Supervised learning algorithms use labeled datasets to map inputs to outputs, while unsupervised algorithms uncover the underlying structure of datasets without labeled data and is used to explore hidden relationships and patterns among data.

DL, a subset of ML, employs artificial neural networks to represent multiple levels of abstraction through computational models85. It can be used in both supervised and unsupervised fashions and consists of feature extraction and classification. Artificial Neural Networks (ANNs) comprise an input layer, one or more hidden layers, and an output layer, with initial training weights and tuning hyperparameters.

ANNs utilize activation functions, allowing DL to model non-linearity. DL algorithms are trained using backpropagation through gradient descent, where backpropagation computes the gradient of the loss function concerning weights and biases, and gradient descent iteratively updates these parameters to improve feature extraction and prediction accuracy.

DL has been employed for cardiovascular image interpretation and the development of models combining clinical and imaging parameters to predict cardiovascular outcomes86. In our review, we explore the ML algorithms, their applications in diagnostic methods for CVDs, and their possible use for more accurate and efficient MI risk prediction and diagnosis in the South Asian population.

Diagnosis of MI

Leveraging ML for improved MI diagnosis in South Asian populations

ML holds significant promise for enhancing MI diagnosis in South Asians, who experience higher incidence and earlier onset compared to other ethnic groups5. Traditional diagnostic tools often fail to account for the unique genetic, environmental, and lifestyle factors contributing to this elevated risk. ML algorithms, particularly convolutional neural networks (CNNs)87, can analyze complex data such as electrocardiograms (ECG) and cardiac biomarkers with high precision, identifying subtle patterns that may be missed by clinicians88. Table 1 provides a comprehensive overview of various ML models and techniques, along with their advantages and limitations.

Table 1 Overview of machine learning models and techniques with their advantages and limitations
Full size table

MI diagnosis traditionally relies on clinical history, ECG changes, and biomarkers like troponins89. However, these methods can yield inconclusive results, particularly in atypical cases. Gupta et al. noted that South Asian patients with MI may take longer to seek medical attention after the onset of symptoms, which can complicate timely diagnosis and management90. ML models can enhance diagnostic accuracy by integrating multimodal data from ECG, and biomarkers, providing a comprehensive assessment in a shorter time frame91. ML algorithms have shown promise in diagnosing myocardial infarction (MI) and predicting short-term outcomes, demonstrating significant improvements over traditional methods, as detailed in Tables 2 and 3. These advancements highlight the potential for tailored approaches to enhance cardiovascular care and management in diverse patient populations. This integrative approach could be crucial for the South Asian population, where ML can improve the identification of atypical presentations90.

Table 2 Studies assessing machine learning algorithms for acute myocardial infarction diagnosis.
Full size table
Table 3 Studies assessing machine learning algorithms for short-term (in-hospital) outcomes of acute myocardial infarction.
Full size table

Personalized diagnostic approaches enabled by ML consider individual risk factors unique to South Asians, including higher rates of diabetes and central obesity, tailoring assessments to the specific risk profile of each patient90. This personalization enhances the relevance and accuracy of diagnoses. Additionally, ML reduces diagnostic errors by providing consistent and objective analyses of diagnostic data, minimizing the risk of human error92. The complexity of integrating and interpreting multiple diagnostic tests often leads to errors; however, ML algorithms can automatically interpret ECG signals and imaging results, ensuring more reliable diagnoses.

Moreover, ML optimizes healthcare resources by prioritizing high-value diagnostic tests and reducing unnecessary procedures, which is particularly beneficial in resource-limited settings in South Asian countries93. This efficiency ensures patients receive appropriate and timely care. Incorporating ML into MI diagnosis also addresses health disparities in access and quality of cardiovascular care. ML-driven mobile health applications can facilitate early detection and continuous monitoring of cardiovascular health in remote or underserved areas93. It must be noted that Machine Learning for risk prediction has limitations when applied in clinical settings. Traditional ML models may not be able to overcome confounding factors or biases that are inherent to the training data. Careful consideration of the quality of training data is necessary, and additional strategies by the clinician must be made to mitigate these biases to ensure accurate outcomes in clinical decision-making.

In summary, ML could significantly enhance MI diagnosis in the South Asian population by improving diagnostic accuracy, integrating multimodal data, and identifying atypical presentations94. ML may provide personalized diagnostic approaches, reduce errors, and optimize healthcare resources. These algorithms can generate differential diagnoses, suggest high-value tests, and minimize repeated testing. Beyond diagnostics, ML may be able to predict patient outcomes and assist in clinical decision-making by providing insights based on large datasets, helping clinicians tailor treatment plans effectively95. These advancements are crucial for addressing the unique challenges faced by South Asians in cardiovascular health, ensuring better clinical outcomes for this high-risk population.

Electrocardiogram

Electrocardiograms (ECG) are non-invasive, low-cost tools essential for detecting abnormal cardiac activity through analysis of electrical impulses, providing important information for MI diagnosis89. However, traditional ECG interpretation is limited by the complexity and variability of cardiac signals, which can obscure subtle but clinically significant patterns88. ML algorithms can enhance ECG analysis by segmenting and classifying signals using supervised and unsupervised learning, thereby improving diagnostic accuracy and clinician productivity88,96.

Supervised learning algorithms, such as logistic regression, support vector machines, ANNs, and random forests, are widely used for ECG classification, aiding disease diagnosis and risk stratification92,94,97. Unsupervised learning methods, including principal component analysis (PCA), help discover hidden patterns in ECG datasets by reducing dimensionality and managing large volumes of signals. This approach can identify phenotypic subtypes in conditions like hypertrophic cardiomyopathy and cluster biomarkers associated with MI97,98. Nonetheless, overfitting remains a challenge in ML, where models perform well on training sets but poorly on unseen data.

DL architectures, such as autoencoders, deep belief networks (DBNs), convolutional neural networks (CNNs), and recurrent neural networks (RNNs), mitigate overfitting and improve ECG classification through hierarchical feature extraction98,99. RNNs perform recursion by directing the sequence of nodes connected in a chain, where the output of each node is used as input for the next. RNNs are suitable for time-series data like ECG signals but face limitations in learning long-term dependencies for long sequence inputs. Long Short-Term Memory (LSTM)100 networks address this issue and are popular algorithms for ECG diagnosis. By combining forward and backward LSTMs, bidirectional LSTM101 networks analyze ECG signals using information from both the future and the past, enhancing the accuracy and robustness of ECG signal analysis.

Advanced DL techniques for ECG classification

Advances DL approaches have demonstrated exceptional performance in ECG classification, addressing challenges such as overfitting and the need for hand-crafted features. Stacked autoencoders, comprising multiple layers of autoencoders and a classifier, learn robust representations through complex relationships102. For ECG classification, denoising and sparse autoencoders can enhance feature detection102.

In addition to stacked auto-encoders, DBNs, composed of stacked restricted Boltzmann machines (RBMs), are generative neural networks utilizing unsupervised learning modules to predict probability distributions over inputs. During pre-training and fine-tuning of the ECG dataset for classifying MI, each RBM is trained sequentially using contrastive divergence to learn initial weights, followed by backpropagation to optimize discriminative performance with labeled data. DBNs perform well even with corrupted data, although achieving high classification accuracy can be challenging98.

CNNs, a form of feedforward neural network characterized by a hierarchical structure, are predominantly used for image-based datasets in DL. Unlike fully connected neural networks, where every layer is connected, CNNs learn filters that apply operations to each sub-region of the input. Architecturally, CNNs consist of convolutional filters, pooling modules, and fully connected layers. Convolutional layers perform the convolution of each sub-region of the input with a filter kernel, extracting features from the input provided by previous layers103. Pooling layers reduce the dimensions of feature maps, retaining essential information while lowering computational complexity. Fully connected layers integrate features extracted by convolutional and pooling layers for final classification.

Several advanced CNN architectures, like AlexNet and VGG-Net, improve performance by using deeper networks and smaller convolutional filters103,104. A deep CNN developed by Acharya et al.94 for detecting MI achieved an accuracy of 93.53% using ECG94. Xiong et al.105 reported the highest accuracy for MI localization using ResNet106, achieving 99.99% accuracy, followed by 99.95% using a convolutional neural network.

Despite these accomplishments, CNNs face several limitations in MI detection. Access to high-quality and large datasets is a major challenge. The performance of DL algorithms often lacks standardized measurement and comparison across different experimental settings, many of which are arbitrary. Additionally, robustness is an issue, as ECG waveforms in clinical settings can be deformed by external forces, potentially affecting DL performance in real-life environments. In summary, advanced ML and DL techniques significantly enhance ECG classification and cardiac disease diagnosis, though challenges such as data quality, model robustness, and interpretability remain.

Cardiac biomarkers

Cardiac biomarkers are proteins released into the blood following cardiac injury, crucial for diagnosing acute MI107. Aydin et al. identified myoglobin, fatty acid-binding protein (FABP), and glycogen phosphorylase BB (GPBB) as early biomarkers for MI, while troponin T (TnT) and troponin I (TnI) are definitive biomarkers for MI diagnosis107. Troponin I (TnI) is currently regarded as the gold standard for diagnosing acute MI, with elevated troponin levels at 0, 3, and 6 hours, offering critical insights into the severity and timing of myocardial injury.

The myocardial-ischemic-injury index (MI3), an ML algorithm developed by Than et al.108, incorporates age, sex, and cardiac high-sensitivity troponins measured in paired samples. This model was trained on a cohort of 3,013 patients and validated on 7,998 individuals presenting with suspected MI. MI occurred in 10.6% of patients in the test set and 13.4% in the training set. The MI3 index effectively identified low and high-risk patients using a gradient boosting algorithm, allowing for individualized and objective assessments of the likelihood of MI, thus enhancing patient care. The MI3 algorithm computes a value between 1 and 100, reflecting an individual’s likelihood of an MI diagnosis109. Despite its potential, gradient boosting is prone to overfitting and is computationally expensive. Current diagnosis of MI relies on fixed troponin thresholds, which does not account for varying troponin levels based on age, sex, or time.

Doudesis et al.109 validated the MI3 algorithm through an exploratory analysis using a multicenter randomized trial conducted in Scotland. Among 20,761 patients, 3,272 (15.8%) had an MI. The MI3 algorithm demonstrated a clear area under the receiver-operating characteristic curve of 95%, identifying 12,983 (62.5%) patients as having a low probability of MI at a prespecified threshold, with a negative predictive value of 99.8%. Additionally, 2,961 patients were identified as having a high probability, with a positive predictive value of 70.4%. At one year, subsequent MI or cardiovascular deaths occurred more frequently in high-probability patients than in low-probability patients (17.6% vs. 0.5%; p < 0.001). These results suggest that the MI3 algorithm is a potential tool for improving the accuracy of MI diagnosis by accounting for varying troponin levels, age, gender, and time, thus allowing for more personalized and accurate risk assessments. Multilayer Perceptrons (MLPs) are another ML algorithm that can be used to classify cardiac biomarkers. MLPs comprise multiple layers of neurons, each fully connected to the next, allowing them to capture complex patterns in the data. These advanced algorithms can enable a more nuanced analysis of cardiac biomarkers.

In summary, leveraging cardiac biomarkers such as troponins with innovative ML algorithms like MI3 offers a more personalized and accurate approach to diagnosing and managing MI. These advancements hold promise for significantly improving clinical outcomes in patients with suspected acute MI. ML algorithms such as VGG-Net and CNNs utilize image datasets, achieving high accuracy in diagnosing MI110. However, there are limitations, such as a lack of access to quality datasets and challenges in evaluating dataset quality. Significantly less research has focused on assessing the information quality in datasets111, and high-quality datasets are essential for developing and training ML algorithms, particularly in MI detection. To address these challenges, a user-centric, ML-based information quality evaluation tool for assessing the quality of MI datasets across three dimensions—consistency, relevance, and accuracy—could prove useful. Consistency measured using edit distance and cosine similarity, relevance assessed by Jaccard similarity and distance, and accuracy evaluated using KL divergence, the Kolmogorov-Smirnov test, and Pearson correlation can enable us to quantify the dataset’s information quality.

Transformer-based models in MI

Based on the Transformer model, the advanced ML algorithm categorizes MI risk into low, medium, and high probability levels. Transformer models have achieved advanced performance in various tasks, including machine translation, language generation, image classification, and object detection111,112,113. By providing a probabilistic classification, the Transformer model aids in patient stratification and tailored interventions.

Transformer-based models, originally introduced for neural machine translation, have revolutionized natural language processing (NLP) by significantly improving sequence translation accuracy through the attention mechanism114. This addresses fixed-length vector problems by allowing a joint soft search of the source sentence, thus improving translation accuracy. Encoder-decoder architectures have been the state of the art for translation tasks. However, while translating sequences, the decoder could not gain the context of previous vectors in a sequence of sentences. Due to this, translation accuracy was low.

Attention mechanisms overcame this limitation, enhancing translation performance by allowing a joint soft search of the source sentence without facing bottlenecks of a fixed vector, thereby improving translation accuracy. Transformers, introduced by Vaswani et al.112, are solely based on the attention mechanism, dispensing with recurrence and convolution entirely, achieving state-of-the-art results in machine translation112. Subsequently, Transformers have been applied to computer vision113,115 and speech recognition, achieving advanced performance across numerous ML tasks111,116,117.

Based on transformers, subsequent generations of language models were developed. Devlin et al.118 introduced Bidirectional Encoder Representations from Transformers (BERT), enabling models to gain a contextual understanding of sentence sequences in machine translation tasks and improving downstream tasks such as text classification, question answering, named entity recognition, and text summarization.

Additionally, Generative Pre-trained Transformers (GPT) by Radford et al.117 utilized only the decoder from Transformers to address natural language generation tasks. GPT-2 increased the capacity and size of parameters, further enhancing natural language generation119. GPT-3 achieved excellent results in many natural language processing tasks, while GPT-4 further increased parameter size and introduced multi-modality, handling both image and text inputs. Recent work by Bubeck et al.120 suggests the emergence of Artificial General Intelligence using a GPT-based ML model.

Despite the significant technical progress of language models in ML, their utilization in the field of cardiology is still in its early stages, with considerable gaps in research and application of language models. However, language models hold great potential for diagnosing and managing MI. An innovative vision transformer, HeartBEiT, developed by Vaid et al.121, demonstrates superior diagnostic performance for ECG analysis compared to traditional CNN architectures, particularly in low-data regimes. This model, pre-trained on a vast body of ECGs, enhances explainability and improves diagnosis by highlighting important regions of the ECG.

Selivanov et al.122 demonstrated the potential of language models in medical image captioning by combining radiological images with organized patient data from textual records, generating summaries that aid in diagnosis and treatment planning. Moreover, Bubeck et al.120 demonstrate the capabilities of GPT-4 in mastering medical natural language processing tasks, such as clinical question answering, note generation, and treatment plan generation. Training medical datasets using GPT-4 can significantly improve the prediction of MI. Beyond prediction, GPT-4 can identify at-risk patients and generate tailored treatment plans for those likely to suffer from acute MI, thereby enhancing patient care and outcomes.

In summary, leveraging advanced Transformer-based models alongside innovative ML algorithms like HeartBEiT and GPT-4 offers a more personalized and accurate approach to diagnosing and managing MI. These advancements hold promise for significantly improving clinical outcomes in patients suspected of acute MI.

Clinical implications and future directions

The integration of ML and DL algorithms in the risk prediction, diagnosis, and short- and long-term prognosis of MI can have important clinical implications and offer significant improvements over traditional methods. ML algorithms, particularly CNNs and transformer models, have demonstrated superior performance in analyzing complex data from ECGs and cardiac biomarkers and can detect subtle patterns often missed by clinicians, improving diagnostic accuracy94. This helps prioritize resources, particularly in resource-limited settings in South Asia, ensuring timely and appropriate care or referral. ML algorithms specifically can help in triaging patients in the emergency department108. ML can offer clinical decision support by simultaneously and rapidly analyzing vast amounts of data, offering insights into treatment plans122. Thus, the integration of ML and DL holds promise for improving risk prediction, enhancing accuracy, and enabling efficiency in MI diagnosis and management, specifically for the South Asian population. Generative artificial intelligence (AI) powered tools, such as virtual co-pilots, can support clinicians by offering real-time, personalized health recommendations that account for individual genetic, lifestyle, and environmental factors. Furthermore, AI platforms can deliver culturally tailored health education, improving patient understanding and engagement. Integrating these advanced AI technologies into clinical practice has the potential to significantly improve secondary cardiovascular prevention strategies, particularly in high-risk populations.

Despite significant advances in ML and DL, several knowledge gaps remain. One of the main challenges is the lack of high-quality and standardized datasets. Many ML models are trained on datasets with poor consistency, thereby impacting their generalizability and robustness in clinical settings105 The current ML models in myocardial infarction do not capture the unique genetic, environmental, and lifestyle factors of South Asian populations, leading to underestimation of MI risk in these groups, thereby noting the need for risk assessments tailored to different ethnic groups12 More comprehensive ML models integrating multimodal data are required. Establishing global standards to improve the quality of datasets will enable proper training of machine learning models. The most important step is translating ML algorithms into actual clinical practice. Collaborative efforts are needed between researchers, clinicians, and policymakers to ensure the accessibility of ML tools to diverse populations.

Conclusions

In conclusion, MI significantly impacts global health, particularly in South Asian populations with higher incidence and earlier onset. Traditional risk scores often fail to capture the unique genetic, environmental, and lifestyle factors contributing to this elevated risk. Advanced ML and DL techniques, such as CNNs and transformer-based models, show substantial promise in enhancing MI detection, prediction, and management by integrating multimodal data and identifying subtle patterns missed by clinicians. Developing tailored MI risk scores for South Asians, incorporating genetic, economic, sociological, and dietary factors, is essential for effective prevention and early interventions. Ensuring high-quality datasets is crucial for these ML models to be clinically applicable. Leveraging these advanced tools can significantly improve cardiovascular outcomes and quality of life for at-risk populations.

Related Articles

Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects

The muscular system plays a critical role in the human body by governing skeletal movement, cardiovascular function, and the activities of digestive organs. Additionally, muscle tissues serve an endocrine function by secreting myogenic cytokines, thereby regulating metabolism throughout the entire body. Maintaining muscle function requires iron homeostasis. Recent studies suggest that disruptions in iron metabolism and ferroptosis, a form of iron-dependent cell death, are essential contributors to the progression of a wide range of muscle diseases and disorders, including sarcopenia, cardiomyopathy, and amyotrophic lateral sclerosis. Thus, a comprehensive overview of the mechanisms regulating iron metabolism and ferroptosis in these conditions is crucial for identifying potential therapeutic targets and developing new strategies for disease treatment and/or prevention. This review aims to summarize recent advances in understanding the molecular mechanisms underlying ferroptosis in the context of muscle injury, as well as associated muscle diseases and disorders. Moreover, we discuss potential targets within the ferroptosis pathway and possible strategies for managing muscle disorders. Finally, we shed new light on current limitations and future prospects for therapeutic interventions targeting ferroptosis.

Different types of cell death and their interactions in myocardial ischemia–reperfusion injury

Myocardial ischemia–reperfusion (I/R) injury is a multifaceted process observed in patients with coronary artery disease when blood flow is restored to the heart tissue following ischemia-induced damage. Cardiomyocyte cell death, particularly through apoptosis, necroptosis, autophagy, pyroptosis, and ferroptosis, is pivotal in myocardial I/R injury. Preventing cell death during the process of I/R is vital for improving ischemic cardiomyopathy. These multiple forms of cell death can occur simultaneously, interact with each other, and contribute to the complexity of myocardial I/R injury. In this review, we aim to provide a comprehensive summary of the key molecular mechanisms and regulatory patterns involved in these five types of cell death in myocardial I/R injury. We will also discuss the crosstalk and intricate interactions among these mechanisms, highlighting the interplay between different types of cell death. Furthermore, we will explore specific molecules or targets that participate in different cell death pathways and elucidate their mechanisms of action. It is important to note that manipulating the molecules or targets involved in distinct cell death processes may have a significant impact on reducing myocardial I/R injury. By enhancing researchers’ understanding of the mechanisms and interactions among different types of cell death in myocardial I/R injury, this review aims to pave the way for the development of novel interventions for cardio-protection in patients affected by myocardial I/R injury.

First-principles and machine-learning approaches for interpreting and predicting the properties of MXenes

MXenes are a versatile family of 2D inorganic materials with applications in energy storage, shielding, sensing, and catalysis. This review highlights computational studies using density functional theory and machine-learning approaches to explore their structure (stacking, functionalization, doping), properties (electronic, mechanical, magnetic), and application potential. Key advances and challenges are critically examined, offering insights into applying computational research to transition these materials from the lab to practical use.

Type 2 immunity in allergic diseases

Significant advancements have been made in understanding the cellular and molecular mechanisms of type 2 immunity in allergic diseases such as asthma, allergic rhinitis, chronic rhinosinusitis, eosinophilic esophagitis (EoE), food and drug allergies, and atopic dermatitis (AD). Type 2 immunity has evolved to protect against parasitic diseases and toxins, plays a role in the expulsion of parasites and larvae from inner tissues to the lumen and outside the body, maintains microbe-rich skin and mucosal epithelial barriers and counterbalances the type 1 immune response and its destructive effects. During the development of a type 2 immune response, an innate immune response initiates starting from epithelial cells and innate lymphoid cells (ILCs), including dendritic cells and macrophages, and translates to adaptive T and B-cell immunity, particularly IgE antibody production. Eosinophils, mast cells and basophils have effects on effector functions. Cytokines from ILC2s and CD4+ helper type 2 (Th2) cells, CD8 + T cells, and NK-T cells, along with myeloid cells, including IL-4, IL-5, IL-9, and IL-13, initiate and sustain allergic inflammation via T cell cells, eosinophils, and ILC2s; promote IgE class switching; and open the epithelial barrier. Epithelial cell activation, alarmin release and barrier dysfunction are key in the development of not only allergic diseases but also many other systemic diseases. Recent biologics targeting the pathways and effector functions of IL4/IL13, IL-5, and IgE have shown promising results for almost all ages, although some patients with severe allergic diseases do not respond to these therapies, highlighting the unmet need for a more detailed and personalized approach.

Higher income is associated with greater life satisfaction, and more stress

Is there a cost to our well-being from increased affluence? Drawing upon responses from 2.05 million U.S. adults from the Gallup Daily Poll from 2008 to 2017 we find that with household income above ~$63,000 respondents are more likely to experience stress. This contrasts with the trend below this threshold, where at higher income the prevalence of stress decreases. Such a turning point for stress was also found for population sub-groups, divided by gender, race, and political affiliation. Further, we find that respondents who report prior-day stress have lower life satisfaction for all income and sub-group categories compared to the respondents who do not report prior-day stress. We find suggestive evidence that among the more satisfied, healthier, socially connected, and those not suffering basic needs deprivations, this turn-around in stress prevalence starts at lower values of income and stress. We hypothesize that stress at higher income values relates to lifestyle factors associated with affluence, rather than from known well-being deprivations related to good health and social conditions, which may arise even at lower income values if conventional needs are met.

Responses

Your email address will not be published. Required fields are marked *